Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-18-021010
Filing Date
2018-04-18
Accepted
2018-04-17 19:12:42
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-1/A tv491258_s1a.htm S-1/A 466534
2 EXHIBIT 4.17 tv491258_ex4-17.htm EX-4.17 23739
3 EXHIBIT 5.1 tv491258_ex5-1.htm EX-5.1 11328
4 EXHIBIT 8.1 tv491258_ex8-1.htm EX-8.1 7655
5 EXHIBIT 23.1 tv491258_ex23-1.htm EX-23.1 2514
6 EXHIBIT 99.1 tv491258_ex99-1.htm EX-99.1 25996
7 EXHIBIT 99.2 tv491258_ex99-2.htm EX-99.2 11669
8 EXHIBIT 99.3 tv491258_ex99-3.htm EX-99.3 15175
9 EXHIBIT 99.4 tv491258_ex99-4.htm EX-99.4 12697
10 EXHIBIT 99.5 tv491258_ex99-5.htm EX-99.5 14929
11 EXHIBIT 99.6 tv491258_ex99-6.htm EX-99.6 16217
12 EXHIBIT 99.7 tv491258_ex99-7.htm EX-99.7 6918
13 GRAPHIC tv491258_ex4-17img1.jpg GRAPHIC 26654
14 GRAPHIC tv491258_ex5-1img1.jpg GRAPHIC 12746
15 GRAPHIC tv491258_ex8-1img1.jpg GRAPHIC 13385
  Complete submission text file 0001144204-18-021010.txt   689689
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-222918 | Film No.: 18760011
SIC: 2836 Biological Products, (No Diagnostic Substances)